全文获取类型
收费全文 | 1745篇 |
免费 | 174篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 114篇 |
妇产科学 | 61篇 |
基础医学 | 214篇 |
口腔科学 | 70篇 |
临床医学 | 139篇 |
内科学 | 460篇 |
皮肤病学 | 50篇 |
神经病学 | 66篇 |
特种医学 | 203篇 |
外科学 | 139篇 |
综合类 | 100篇 |
预防医学 | 105篇 |
眼科学 | 16篇 |
药学 | 114篇 |
中国医学 | 5篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 18篇 |
2022年 | 20篇 |
2021年 | 40篇 |
2020年 | 24篇 |
2019年 | 20篇 |
2018年 | 32篇 |
2017年 | 55篇 |
2016年 | 50篇 |
2015年 | 40篇 |
2014年 | 77篇 |
2013年 | 86篇 |
2012年 | 45篇 |
2011年 | 57篇 |
2010年 | 79篇 |
2009年 | 77篇 |
2008年 | 52篇 |
2007年 | 103篇 |
2006年 | 67篇 |
2005年 | 52篇 |
2004年 | 38篇 |
2003年 | 31篇 |
2002年 | 31篇 |
2001年 | 53篇 |
2000年 | 28篇 |
1999年 | 33篇 |
1998年 | 83篇 |
1997年 | 76篇 |
1996年 | 70篇 |
1995年 | 61篇 |
1994年 | 53篇 |
1993年 | 53篇 |
1992年 | 29篇 |
1991年 | 23篇 |
1990年 | 39篇 |
1989年 | 36篇 |
1988年 | 42篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 23篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 15篇 |
1975年 | 15篇 |
1973年 | 3篇 |
排序方式: 共有1968条查询结果,搜索用时 15 毫秒
41.
Hiroshi Nakashima Johanna K. Kaufmann Pin-Yi Wang Tran Nguyen Maria-Carmela Speranza Kazue Kasai Kazuo Okemoto Akihiro Otsuki Ichiro Nakano Soledad Fernandez William F. Goins Paola Grandi Joseph C. Glorioso Sean Lawler Timothy P. Cripe E. Antonio Chiocca 《The Journal of clinical investigation》2015,125(11):4269-4280
Oncolytic viral (OV) therapy, which uses genetically engineered tumor-targeting viruses, is being increasingly used in cancer clinical trials due to the direct cytolytic effects of this treatment that appear to provoke a robust immune response against the tumor. As OVs enter tumor cells, intrinsic host defenses have the potential to hinder viral replication and spread within the tumor mass. In this report, we show that histone deacetylase 6 (HDAC6) in tumor cells appears to alter the trafficking of post-entry OVs from the nucleus toward lysosomes. In glioma cell lines and glioma-stem–like cells, HDAC6 inhibition (HDAC6i) by either pharmacologic or genetic means substantially increased replication of oncolytic herpes simplex virus type 1 (oHSV). Moreover, HDAC6i increased shuttling of post-entry oHSV to the nucleus. In addition, electron microscopic analysis revealed that post-entry oHSVs are preferentially taken up into glioma cells through the endosomal pathway rather than via fusion at the cell surface. Together, these findings illustrate a mechanism of glioma cell defense against an incoming infection by oHSV and identify possible approaches to enhance oHSV replication and subsequent lysis of tumor cells. 相似文献
42.
43.
Procedural variation in the performance of primary percutaneous coronary intervention for ST‐elevation myocardial infarction: A SCAI‐based survey study of US interventional cardiologists 下载免费PDF全文
Austin Chiang MD Hemal Gada MD MBA Susheel K. Kodali MD Michael S. Lee MD Allen Jeremias MD Duane S. Pinto MD MPH Sripal Bangalore MD MHA Robert W. Yeh MD MSc Timothy D. Henry MD Georgina Lopez‐Cruz BS MSHA Roxana Mehran MD Ajay J. Kirtane MD SM 《Catheterization and cardiovascular interventions》2014,83(5):721-726
44.
45.
46.
47.
Marwan SM Al-Nimer 《World journal of diabetes》2022,13(5):417-419
Hyperandrogenism and hyperinsulinemia have resulted from dysfunction of the theca cell of the ovary and adipose tissue and each one potentiates the other in patients with androgen excess disorders e.g., polycystic ovary disease and idiopathic hirsutism. Possible external and/or internal triggers can produce such cellular dysfunction. There is evidence that sodium valproate acts as a trigger of cellular dysfunction and produces both hyperinsulinemia and hyperandrogenism. Therefore, the elimination of these triggers can help the patients to recover from hyperinsulinemia, insulin resistance and hyperandrogenism. 相似文献
48.
49.
Antonella Napolitano Renata Zanin Federica Palma Cecilia Romani Giovanni Grandi Costantino Di Carlo 《The European journal of contraception & reproductive health care》2016,21(2):168-175
Objective The effect on body composition and in particular on fat mass (FM) of 12 months’ use of a desogestrel (DSG)-only contraceptive pill or the levonorgestrel-releasing intrauterine system (LNG-IUS) was evaluated in women in the perimenopause.Methods An observational study comprised 102 perimenopausal women: 42 received a 75 μg DSG pill, 34 received the 52 mg LNG-IUS, and 26 received no treatment. Body composition, body weight and resting metabolic rate (RMR) were evaluated at baseline and again after 12 months.Results FM did not change in the control group (? 0.5 ± 1.6%) but significantly increased in the LNG-IUS group (+ 1.1 ± 2.9%; p = 0.02 vs. controls) and in the DSG group (+ 2.8 ± 3.5%; p = 0.0001 vs. controls; p = 0.02 vs. LNG-IUS). Women treated with DSG or the LNG-IUS showed a non-significant increase in body weight, body mass index and waist circumference. RMR did not significantly vary in the control group (? 3.8 ± 292.9 kJ/ 24 h) and tended to decrease but not significantly in the LNG-IUS (115.5 ± 531.8 kJ/ 24 h) and DSG groups (305.9 ± 556.9 kJ/24 h).Conclusions The results of this preliminary study seem to indicate that in perimenopausal women continuous use of the DSG-only pill and to a lesser extent the LNG-IUS may favour FM accumulation. 相似文献